A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,103,166 shares of TEVA stock, worth $37.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,103,166
Previous 527,000 299.08%
Holding current value
$37.6 Million
Previous $7.44 Million 359.66%
% of portfolio
0.07%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $20.1 Million - $27.4 Million
1,576,166 Added 299.08%
2,103,166 $34.2 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $4.28 Million - $5.6 Million
527,000 New
527,000 $5.5 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $2.81 Million - $4.78 Million
-250,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $3.85 Million - $8.04 Million
250,000
250,000 $4.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.